[["the aim of this study", "was to investigate", "whether patients with systolic heart failure and abnormal thyroid function are at increased risk for death"], ["thyroid hormone homeostasis", "is vital to", "the optimal functioning of the cardiovascular system"], ["an independent prognostic effect of thyroid abnormalities", "has not been established", "in patients with heart failure"], ["thyroid-stimulating hormone (TSH)", "was measured", "at baseline and at 6-month intervals throughout the 5-year study"], ["the majority of patients", "had", "normal TSH levels at baseline"], ["12% of patients", "had", "values suggestive of hypothyroidism"], ["1% of patients", "had", "values consistent with hyperthyroidism"], ["hypothyroid patients", "were", "older and included more women and Caucasians compared to euthyroid patients"], ["patients randomized to amiodarone", "had", "an elevated risk for developing abnormal TSH levels"], ["patients with baseline or new-onset abnormal thyroid function", "had", "a higher mortality than those with normal thyroid function"], ["the hazard ratio for hypothyroid patients", "was", "1.58"], ["the hazard ratio for hyperthyroid patients", "was", "1.85"], ["implantable cardioverter-defibrillator benefit", "did not vary", "with thyroid function"], ["abnormal thyroid function in patients with symptomatic heart failure", "is associated with", "significantly increased risk for death"]]